{
  "label": "clinical_signal_03_ep_011",
  "artifact_type": "signal_episode",
  "artifact_id": "sha256:d6097481bdcbe0849f28a3a36847fcab538d2ebd5fe931af4484b736d7e7fbf9",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:161174e8025b5c956602ccc4e17b4e677c58230b1b64641f357c400c448b8151"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:54:38.503352",
  "content": "## 2024-05-13 Daily Operations Summary\n\n### Enrollment\n- Total Randomized: 189\n- Active: 182\n- Screen Failures Cumulative: 27\n- Withdrawals Cumulative: 7\n\n#### Sites\n- Site 01\n  - Enrolled: 19\n  - Active: 19\n  - Statin Concomitant: 5\n- Site 02\n  - Enrolled: 14\n  - Active: 14\n  - Statin Concomitant: 3\n- Site 03\n  - Enrolled: 17\n  - Active: 17\n  - Statin Concomitant: 5\n- Site 04\n  - Enrolled: 12\n  - Active: 12\n  - Statin Concomitant: 3\n- Site 05\n  - Enrolled: 16\n  - Active: 16\n  - Statin Concomitant: 4\n- Site 06\n  - Enrolled: 11\n  - Active: 11\n  - Statin Concomitant: 3\n- Site 07\n  - Enrolled: 21\n  - Active: 21\n  - Statin Concomitant: 6\n- Site 08\n  - Enrolled: 14\n  - Active: 14\n  - Statin Concomitant: 3\n- Site 09\n  - Enrolled: 16\n  - Active: 16\n  - Statin Concomitant: 4\n- Site 10\n  - Enrolled: 12\n  - Active: 12\n  - Statin Concomitant: 3\n- Site 11\n  - Enrolled: 17\n  - Active: 17\n  - Statin Concomitant: 5\n- Site 12\n  - Enrolled: 14\n  - Active: 14\n  - Statin Concomitant: 4\n\n### Lab Panels\n#### Statin Subgroup\n- N: 55\n- ALT (U/L) Mean: 47.6\n- ALT (U/L) Median: 47.4\n- AST (U/L) Mean: 35.8\n- AST (U/L) Median: 34.3\n- Bilirubin (mg/dL) Mean: 0.7\n- Bilirubin (mg/dL) Median: 0.67\n- ALP (U/L) Mean: 67.5\n- ALP (U/L) Median: 61.8\n- Creatinine (mg/dL) Mean: 0.8\n- Creatinine (mg/dL) Median: 0.86\n- BUN (mg/dL) Mean: 13.5\n- BUN (mg/dL) Median: 15.1\n- WBC (K) Mean: 6.7\n- WBC (K) Median: 5.6\n- Platelets (K) Mean: 258\n- Platelets (K) Median: 256\n\n#### Non-Statin Subgroup\n- N: 132\n- ALT (U/L) Mean: 29.3\n- ALT (U/L) Median: 29.2\n- AST (U/L) Mean: 25.5\n- AST (U/L) Median: 25.2\n- Bilirubin (mg/dL) Mean: 0.46\n- Bilirubin (mg/dL) Median: 0.44\n- ALP (U/L) Mean: 53.2\n- ALP (U/L) Median: 50.8\n- Creatinine (mg/dL) Mean: 0.96\n- Creatinine (mg/dL) Median: 0.83\n- BUN (mg/dL) Mean: 17.5\n- BUN (mg/dL) Median: 11.1\n- WBC (K) Mean: 6.7\n- WBC (K) Median: 7.4\n- Platelets (K) Mean: 247\n- Platelets (K) Median: 232\n\n### Adverse Events\n- AE ID: AE-0033\n  - Description: nausea\n  - Grade: 1\n  - Relatedness: possibly related\n  - Resolved: true\n  - Subject Group: statin\n- AE ID: AE-0034\n  - Description: insomnia\n  - Grade: 1\n  - Relatedness: unlikely related\n  - Resolved: true\n  - Subject Group: non_statin\n- AE ID: AE-0035\n  - Description: transaminase measurement out of range\n  - Grade: 1\n  - Relatedness: possibly related\n  - Resolved: true\n  - Subject Group: statin\n\n### Concomitant Meds\n- Statin Count: 51\n- ACE Inhibitor Count: 26\n- Metformin Count: 22\n- PPI Count: 17\n- NSAID Count: 12\n- Other Count: 34\n\n### Protocol Deviations\n- PD ID: PD-025\n  - Description: Concomitant medication not recorded at visit\n  - Severity: minor\n  - Site: site_01\n\n### Investigator Notes\n- Subject retention rate within protocol targets\n- EDC data entry backlog cleared, queries resolved\n\n### Events\n- Drug accountability audit at Site 04: no discrepancies\n- Site 09 pharmacy temperature log reviewed: compliant\n- Central lab courier pickup schedule adjusted for holiday\n\n### Notes\n- Week 11: Statin subgroup hepatic panel shows ALT values at upper range. Non-statin subgroup stable. Routine operations continue.",
  "metadata": {
    "episode_id": "clinical_signal_03_ep_011",
    "scope_id": "clinical_signal_03",
    "timestamp": "2024-05-13T10:00:00",
    "phase": "early_signal",
    "signal_density": "low",
    "episode_type": "signal",
    "layer_name": "signal_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "724335e48952198659b608a79f591f6985cc457d1b0726c271a193e4d218a284",
      "components": {
        "transform": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
        "inputs": "a94b84fbaca9bd62"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
      "components": {
        "transform_id": "cb4ddfa83a38701b",
        "source": "42e76241d396a578",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}